Portfolio

ApiFix

Novel treatment option for adolescent idiopathic scoliosis (AIS)

Technology Development

Business Development

Revenue

Exited

Visit Website
Founded

2011

CEO
UN SDGs
3 10
Contact Us
email email
Follow Us
facebook linkedin twitter
Investors
The Trendlines Group; B. Braun; US based family office, Israel Innovation Authority

About

ApiFix® Ltd. developed the ApiFix procedure, a novel treatment option to fill a gap in the treatment of adolescent idiopathic scoliosis (AIS). The procedure offers select AIS patients a less-invasive, motion-preserving option for achieving curve correction.

In 2020, ApiFix was acquired and became a wholly-owned subsidiary of OrthoPediatrics Corp. (Nasdaq: KIDS), focused exclusively on advancing the field of pediatric orthopedics and improving the lives of children with orthopedic conditions.

Market Need

Bracing may be ineffective. Fusion is forever. The ApiFix® procedure offers select adolescent idiopathic scoliosis (AIS) patients a less invasive, motion-preserving option for achieving curve correction – without the permanence of fusion.

Skip to content